ASSESSMENT OF PREVALENCE, RISK FACTORS AND TREATMENT OF DIABETIC FOOT ULCERS IN TYPE - 2 DIABETES PATIENTS
Abstract
Diabetic foot ulcers (DFUs) are among the most serious and disabling complications of type 2 diabetes mellitus, leading to prolonged hospitalisation, infection, lower-limb amputation, and increased mortality, especially in rural populations. This hospital-based retrospective study aimed to assess the prevalence, associated risk factors, and treatment patterns of diabetic foot ulcers among patients with type 2 diabetes mellitus. The study was conducted over a period of six months in the Department of General Surgery at SVS Medical College and Hospital, Mahbubnagar, and included 50 patients diagnosed with diabetic foot ulcers. Demographic data, clinical characteristics, risk factors, laboratory parameters including random blood glucose and HbA1c, ulcer severity, and treatment modalities were analysed using appropriate statistical methods. The results indicated that DFUs were most common among patients aged 50–70 years, with a higher prevalence in males. Hypertension was the predominant risk factor among females, while smoking was more common among males. Mild ulcers were observed in 22 patients, moderate ulcers in 12, and severe ulcers in 16 patients. Treatment strategies primarily included antibiotic therapy, insulin administration, wound dressing, debridement, and pain management. The findings emphasise the importance of early diagnosis, effective glycemic control, risk-factor modification, patient education, and multidisciplinary management to reduce complications and improve clinical outcomes in patients with diabetic foot ulcers.
Downloads
References
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28. doi:10.1001/jama.293.2.217.
3. International Working Group on the Diabetic Foot. Guidelines on the prevention and management of diabetic foot disease. 2023. Available from: https://iwgdfguidelines.org
4. American Diabetes Association. Standards of medical care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S1–S291. doi:10.2337/dc23-Sint.
5. Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJM. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care. 2018;41(4):645–52. doi:10.2337/dc17-1836.
6. Apelqvist J, Bakker K, van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab Res Rev. 2008;24(Suppl 1):S181–7. doi:10.1002/dmrr.848.
7. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management (NG19). 2019. Available from: https://www.nice.org.uk/guidance/ng19
8. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–75. doi:10.1056/NEJMra1615439.
9. International Working Group on the Diabetic Foot. Guidelines on the prevention and management of diabetic foot disease. 2023. Available from: https://iwgdfguidelines.org
10. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and diabetic foot ulceration. Diabetes Care. 2001;24(9):1468–71.
11. Cavanagh PR, Lipsky BA, Bradbury AW. Diabetic foot ulcers: biology, burden, and modern treatment. J Clin Invest. 2005;115(5):1211–17.
12. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13(Suppl 1):S6–11.
13. Armstrong DG, Lavery LA, Harkless LB. Diabetic foot ulcers and their recurrence. Clin Podiatr Med Surg. 1997;14(4):701–17.
14. Orthobullets. Diabetic foot ulcers. Available from: https://www.orthobullets.com/foot-and-ankle/7046/diabetic-foot-ulcers
15. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122.
16. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system that predicts healing rate: the University of Texas system. Diabetes Care. 1998;21(5):855–9.
17. Oyibo SO, Jude EB, Tarawneh I, et al. The use of the SINBAD system in classifying diabetic foot ulcers. Diabetologia. 2001;44(5):666–9.
18. Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections and amputations in diabetic patients. Diabetes Care. 2003;26(5):1435–8.
19. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and diabetic foot ulceration. Diabetes Care. 2001;24(9):1468–71.
20. Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747–87.
21. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy. Arch Neurol. 1993;50(10):1026–32.
22. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.
23. Ledermann HP, Morrison WB, Schweitzer ME. MRI in diabetic foot infections. Radiol Clin North Am. 2002;40(5):1027–40.
24. Aragón-Sánchez J, Lipsky BA, Lázaro-Martínez JL. Diagnostic imaging of infections in the diabetic foot. Int J Low Extrem Wounds. 2011;10(1):16–33.
25. Morrison WB, Schweitzer ME, Bock GW, et al. Osteomyelitis of the foot: relative accuracy of MR imaging and scintigraphy. Radiology. 1998;207(2):505–10.
26. Lipsky BA, Aragón-Sánchez J, Diggle M, et al. Diagnosis of infection in the foot in diabetes: a consensus statement. Clin Infect Dis. 2012;54(12):132–73.
27. Senneville E, Melliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis. J Clin Microbiol. 2006;44(9):3409–12.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
rumanakhan98765@gmail.com


.